Back to mobile site

Wells Fargo Starts ViroPharma (VPHM) at Market Perform; Manufacturing A Concern Despite Solid Cinryze Sales

July 11, 2012 7:05 AM EDT Send to a Friend
Wells Fargo initiates coverage on ViroPharma (NASDAQ: VPHM) with a Market Perform. PT range $24-$26.

Analyst, Brian Abrahams, said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login